Inventors list

Assignees list

Classification tree browser

Top 100 Inventors

Top 100 Assignees


Delahaye, FR

Bruno Delahaye, Egly FR

Patent application numberDescriptionPublished
20080268652Solution used in the fabrication of a porous semiconductor material, and a method of fabricating said material - A solution includes hydrofluoric acid, an alcohol, and a metallic salt, in which the metal has a redox potential that is positive relative to a hydrogen electrode at 25° C.10-30-2008

Delphine Delahaye, Massy FR

Patent application numberDescriptionPublished
20120321714SOLID PHARMACEUTICAL COMPOSITION CONTAINING 6-OXO-6,7,8,9,10,11-HEXAHYDROCYCLOHEPTA (C)CHROMEN-3-YL SULFAMATE AND POLYMORPHS THEREOF - The present invention relates to a solid pharmaceutical composition including the active principle 6-oxo-6,7,8,9,10,11-hexahydrocyclohepta[c]chromen-3-yl sulfamate. The present invention also relates to polymorphs of the 6-oxo-6,7,8,9,10,11-hexahydrocyclohepta[c]chromen-3-yl sulfamate compound.12-20-2012

Laurent Delahaye, Mougins FR

Patent application numberDescriptionPublished
20090118246Therapeutic ophthalmic compositions containing retinal friendly recpients and related methods - Pharmaceutical compositions suitable for administration into the interior of an eye of a person or animal are described. The present compositions include one or more components which are effective in providing a reduced toxicity relative to existing intraocular ophthalmic compositions. The present compositions include one or more therapeutic agents in amounts effective in providing a desired therapeutic effect when placed in an eye, and one or more retinal friendly excipients that have a reduced toxicity relative to benzyl alcohol or polysorbate 80. In certain compositions, the excipient component of the compositions comprises one or more cyclodextrins or cyclodextrin derivatives. Methods of using the compositions to treat ocular conditions are also described.05-07-2009
20090118247Therapeutic ophthalmic compositions containing retinal friendly excipients and related methods - Pharmaceutical compositions suitable for administration into the interior of an eye of a person or animal are described. The present compositions include one or more components which are effective in providing a reduced toxicity relative to existing intraocular ophthalmic compositions. The present compositions include one or more therapeutic agents in amounts effective in providing a desired therapeutic effect when placed in an eye, and one or more retinal friendly excipients that have a reduced toxicity relative to benzyl alcohol or polysorbate 80. In certain compositions, the excipient component of the compositions comprises one or more cyclodextrins or cyclodextrin derivatives. Methods of using the compositions to treat ocular conditions are also described.05-07-2009
20090197846Therapeutic ophthalmic compositions containing retinal friendly excipients and related methods - Pharmaceutical compositions suitable for administration into the interior of an eye of a person or animal are described. The present compositions include one or more components which are effective in providing a reduced toxicity relative to existing intraocular ophthalmic compositions. The present compositions include one or more therapeutic agents in amounts effective in providing a desired therapeutic effect when placed in an eye, and one or more retinal friendly excipients that have a reduced toxicity relative to benzyl alcohol or polysorbate 80. In certain compositions, the excipient component of the compositions comprises one or more cyclodextrins or cyclodextrin derivatives. Methods of using the compositions to treat ocular conditions are also described.08-06-2009
20090197847Therapeutic ophthalmic compositions containing retinal friendly excipients and related methods - Pharmaceutical compositions suitable for administration into the interior of an eye of a person or animal are described. The present compositions include one or more components which are effective in providing a reduced toxicity relative to existing intraocular ophthalmic compositions. The present compositions include one or more therapeutic agents in amounts effective in providing a desired therapeutic effect when placed in an eye, and one or more retinal friendly excipients that have a reduced toxicity relative to benzyl alcohol or polysorbate 80. In certain compositions, the excipient component of the compositions comprises one or more cyclodextrins or cyclodextrin derivatives. Methods of using the compositions to treat ocular conditions are also described.08-06-2009
20090203660Therapeutic ophthalmic compositions containing retinal friendly excipients and related methods - Pharmaceutical compositions suitable for administration into the interior of an eye of a person or animal are described. The present compositions include one or more components which are effective in providing a reduced toxicity relative to existing intraocular ophthalmic compositions. The present compositions include one or more therapeutic agents in amounts effective in providing a desired therapeutic effect when placed in an eye, and one or more retinal friendly excipients that have a reduced toxicity relative to benzyl alcohol or polysorbate 80. In certain compositions, the excipient component of the compositions comprises one or more cyclodextrins or cyclodextrin derivatives. Methods of using the compositions to treat ocular conditions are also described.08-13-2009

Nicolas Delahaye, Rueil-Malmaison FR

Patent application numberDescriptionPublished
20110104136Natural Killer p30 (NKp30) Dysfunction and the Biological Applications Thereof - The present invention relates to a method of assessing a favourable or, on the contrary, an unfavourable prognosis of a cancer in the subject, which method comprises detecting the presence of a mutated Natural Cytotoxicity-triggering Receptor 3 (NCR3) nucleic acid, an abnormal relative amount of at least one particular Natural Killer p30 (NKp30) RNA transcript isoform, and/or an abnormal Natural Killer p30 (NKp30) expression or activity of at least one particular NKp30 protein isoform in a sample from the subject, the presence of said mutated NCR3 nucleic acid, abnormal relative amount of at least one particular NKp30 RNA transcript isoform, or abnormal expression or activity of at least one particular NKp30 protein isoform being indicative of the prognosis of said cancer in the subject.05-05-2011

Nicolas Delahaye, Marly Le Roi FR

Patent application numberDescriptionPublished
20110202637METHOD FOR BUFFERING STREAMING DATA AND A TERMINAL DEVICE - A method of streaming data from a server (S) at a server data rate (Cs) via a network to at least one terminal at a terminal reception data rate (Crec) is provided. A streaming section from the server (S) is requested by the terminal (T). Streaming data is forwarded from the server (S) to the network (N) at a server data rate (Cs) and from the network (N) to the terminal (T) at a reception data rate (Crec). Data received from the network (N) is buffered in the terminal buffer (AL) for at least a first period. The rendering of the buffered data is initiated after the first period at a first rendering rate (Cren), which is lower than the server data rate (Cs) or the reception data rate (Crec). The first rendering data rate (Cren) is adapted according to the filling of the terminal buffer (AL) with received streaming data until the rendering data rate (Cren) corresponds to the server data rate (Cs).08-18-2011

Romain Delahaye, Colomiers FR

Patent application numberDescriptionPublished
20110001006Process for making an aircraft having a floor - The method of fabricating an aircraft comprises the following steps: 01-06-2011
20110001008Aircraft floor of optimized compactness - An aircraft floor portion includes crossmembers. Each crossmember comprises a top partial crossmember and a bottom crossmember, with at least one gap being left between the top partial crossmember and the bottom partial crossmember of each crossmember.01-06-2011
20110147521METHOD OF CONSTRUCTING A FIXED-WING AIRCRAFT - The following steps are performed in the method of constructing an aircraft: taking a subassembly comprising two wings that are rigidly fastened together, and fitting it to a fuselage wall; and fastening the subassembly to the wall by means of fastener elements that are distinct from the subassembly and that present main axes that are vertical.06-23-2011
20120061513AIRCRAFT INCLUDING FLOOR SUPPORT CROSS-MEMBERS WITH BEARINGS INCLUDING A FLEXIBLE MATERIAL CONNECTING THE CROSS-MEMBER TO THE SUPPORT - An aircraft including: at least one floor cross-member; at least one support carrying the cross-member; and at least one bearing including at least one flexible material and connecting the cross-member to the support.03-15-2012
20120066907INSTALLATION FOR MAKING A FUSELAGE PORTION OF AN AIRCRAFT - In the method of making an aircraft a mandrel is caused to pass through frames carried by a magazine; and as it passes through, the frames are transferred onto the mandrel.03-22-2012
20120104170FUSELAGE ELEMENT COMPRISING A FUSELAGE SEGMENT AND JOINING MEANS - The invention relates to a fuselage element comprising a fuselage segment (05-03-2012
20120211602FRAME FOR AN OPENING PROVIDED IN AN AIRCRAFT FUSELAGE - A frame of a door that is provided at an opening made in a fuselage of an aircraft that is delimited by a skin, whereby the frame that includes an upper longitudinal stiffener and a lower longitudinal stiffener provides the connection between two vertical substructures (08-23-2012

Thibaud Delahaye, Blanquefort FR

Patent application numberDescriptionPublished
20100015495Electrochemical Device Comprising a Proton-Conducting Ceramic Electrolyte - The invention relates to the use of a ceramic of formula Ba01-21-2010

Thibaud Delahaye, Saint Martin Le Vinoux FR

Patent application numberDescriptionPublished
20100015489Titanates of Perovskite or Derived Structure and Applications Thereof - Materials of the titanate type of perovskite or derived structure and their uses for the production of electrodes, more particularly in the cell elements of an SOFC cell or the cell elements of a high-temperature steam electrolysis cell.01-21-2010
20110262629METHOD FOR FABRICATING A NICKEL-CERMET ELECTRODE - The method for fabricating a nickel-cermet electrode comprises the steps of formation of a mixture comprising an organic nickel salt in solid state and at least one ceramic material in solid state at ambient temperature, followed by shaping of the mixture and heat treatment of the shaped mixture, preferably under reducing conditions, to form the nickel-cermet electrode. The organic nickel salt is chosen from a nickel acetate, a nickel carbonate and a nickel tartrate.10-27-2011

Thibaud Delahaye, Tresques FR

Patent application numberDescriptionPublished
20110229786ELECTROLYTE PLATE WITH INCREASED RIGIDITY, AND ELECTROCHEMICAL SYSTEM COMPRISING SUCH AN ELECTROLYTE PLATE - An electrolyte plate for an electrochemical system including a first face and a second face, being opposite each other, of largest surface area, the first face including linear parallel ribs and the second face including linear parallel ribs. The plate thus exhibits an increased rigidity without substantially increasing the thickness thereof.09-22-2011
20110253548ELECTROLYTE WITH LOWERED RIGIDITY, AND ELECTROCHEMICAL SYSTEM COMPRISING SUCH AN ELECTROLYTE - An electrolyte plate for an electrochemical system including a first and a second face opposite to each other of larger surface areas, both faces being separated by a given distance. The first face includes linear protrusions and the second face includes linear recesses, the protrusions and the recesses being substantially parallel to each other. Each protrusion is superposed to a recess along a direction substantially orthogonal to a mean plane of the plate, the distance separating a bottom of each recess from a vertex of the superposed protrusion being substantially equal to the distance between the first and the second face so that the electrolyte plate has a substantially constant thickness.10-20-2011
20120186976METAL-SUPPORTED ELECTROCHEMICAL CELL AND METHOD FOR FABRICATING SAME - A metal-supported electrochemical cell is provided. The cell may contain a porous metal support comprising a first- and a second-main surfaces, a porous thermomechanical adaptive layer on the second main surface, a porous layer that is a barrier against the diffusion of chromium on the porous thermomechanical adaptive layer, this porous barrier layer being in stabilised zirconia and/or substituted ceria, and in a mixed oxide of spinel structure, a porous hydrogen electrode layer on the porous barrier layer, a dense electrolyte layer on the porous hydrogen electrode layer; a dense or porous reaction barrier layer on the dense electrolyte layer, and a porous oxygen or air electrode layer on the reaction barrier layer. A method for fabricating a metal-supported electrochemical cell is also provided. The method may comprise a step for the simultaneous sintering of the green support and of all the previously deposited layers in the green state.07-26-2012